Page 300 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 300
Fatty Liver Disease: Clinical (Cont.)
P1034 CHARACTERISATION OF THE PREVALENCE AND RISK
FACTORS FOR BIOPSY-PROVEN NON-ALCOHOLIC
STEATOHEPATITIS AMONG PATIENTS WITH GALLSTONES:
A PROSPECTIVE STUDY
Carmelo Garcia-Monzon*, Javier Vargas-Castrillon, Jose Luis Porrero,
Maria Teresa Alonso, Oscar Bonachia, Maria Jose Castillo,
Alberto Marcos, Esther Quiros, Beatriz Ramos, Carlos Sanchez-
Cabezudo, Sol Villar, Alicia Saez, Javier Rodriguez de Cia,
Elvira Del Pozo, Lorena Vega, Susana Soto-Fernandez, Oreste Lo Iacono,
Maria Eugenia Miquilena-Colina, Spain
P1035 ELF TEST IS A RELIABLE NON INVASIVE TEST FOR
FIBROSIS IN NAFLD SUBJECTS
Luca Miele*, Teresa De Michele, Maria Antonietta Isgrò,
Giuseppe Marrone, Consuelo Cefalo, Marco Biolato,
Gian Lodovico Rapaccini, Antonio Gasbarrini, Cecilia Zuppi,
Antonio Grieco, Italy
P1036 OBESITY, T2DM, METABOLIC SYNDROME INFLUENCE
MORTALITY IN NAFLD IN A COHORT OF MEXICAN
ePOSTERS PATIENTS
Luis A. Perez-Arredondo*, Paula Cordero-Perez, Gabriela Alarcon-
Galvan, Roberto F. Martinez-Macias, Ana Silvera-Linares,
Linda E. Munoz-Espinosa, Mexico
P1037 INFLUENCE OF PREDICTOR VARIABLES ON FIBROMAX
RESULTS
Narina Sargsyants*, Arthur Melkonyan,Yelena Kazanchyan, Armenia
P1038 NON-ALCOHOLIC FATTY LIVER DISEASE IS A COMMON
FINDING IN ASYMPTOMATIC, UNCOMPLICATED
TYPE 2 DIABETES MELLITUS PATIENTS ASSESSED BY
MULTIPARAMETRIC MAGNETIC RESONANCE LIVER
IMAGING
Eylem Levelt, Pavlides Michael*, Catherine Kelly, Masliza Mahmod,
Jane Francis, Jurgen Schneider, Kieran Clarke, Stefan Neubauer,
The United Kingdom
P1039 A REVIEW OF OUTCOMES OF LIVER BIOPSIES IN HIV-
INFECTED PATIENTS WITHOUT HEPATITIS CO-INFECTION
2002-2012
Robert A. Lever*, Rosa Lombardi, Emmanouil Tsochatzis, Colette Smith,
Neal Marshall, Alison Rodger, Sanjay Bhagani, The United Kingdom
300 The International Liver Congress™ 2015 • ILC Programme
P1034 CHARACTERISATION OF THE PREVALENCE AND RISK
FACTORS FOR BIOPSY-PROVEN NON-ALCOHOLIC
STEATOHEPATITIS AMONG PATIENTS WITH GALLSTONES:
A PROSPECTIVE STUDY
Carmelo Garcia-Monzon*, Javier Vargas-Castrillon, Jose Luis Porrero,
Maria Teresa Alonso, Oscar Bonachia, Maria Jose Castillo,
Alberto Marcos, Esther Quiros, Beatriz Ramos, Carlos Sanchez-
Cabezudo, Sol Villar, Alicia Saez, Javier Rodriguez de Cia,
Elvira Del Pozo, Lorena Vega, Susana Soto-Fernandez, Oreste Lo Iacono,
Maria Eugenia Miquilena-Colina, Spain
P1035 ELF TEST IS A RELIABLE NON INVASIVE TEST FOR
FIBROSIS IN NAFLD SUBJECTS
Luca Miele*, Teresa De Michele, Maria Antonietta Isgrò,
Giuseppe Marrone, Consuelo Cefalo, Marco Biolato,
Gian Lodovico Rapaccini, Antonio Gasbarrini, Cecilia Zuppi,
Antonio Grieco, Italy
P1036 OBESITY, T2DM, METABOLIC SYNDROME INFLUENCE
MORTALITY IN NAFLD IN A COHORT OF MEXICAN
ePOSTERS PATIENTS
Luis A. Perez-Arredondo*, Paula Cordero-Perez, Gabriela Alarcon-
Galvan, Roberto F. Martinez-Macias, Ana Silvera-Linares,
Linda E. Munoz-Espinosa, Mexico
P1037 INFLUENCE OF PREDICTOR VARIABLES ON FIBROMAX
RESULTS
Narina Sargsyants*, Arthur Melkonyan,Yelena Kazanchyan, Armenia
P1038 NON-ALCOHOLIC FATTY LIVER DISEASE IS A COMMON
FINDING IN ASYMPTOMATIC, UNCOMPLICATED
TYPE 2 DIABETES MELLITUS PATIENTS ASSESSED BY
MULTIPARAMETRIC MAGNETIC RESONANCE LIVER
IMAGING
Eylem Levelt, Pavlides Michael*, Catherine Kelly, Masliza Mahmod,
Jane Francis, Jurgen Schneider, Kieran Clarke, Stefan Neubauer,
The United Kingdom
P1039 A REVIEW OF OUTCOMES OF LIVER BIOPSIES IN HIV-
INFECTED PATIENTS WITHOUT HEPATITIS CO-INFECTION
2002-2012
Robert A. Lever*, Rosa Lombardi, Emmanouil Tsochatzis, Colette Smith,
Neal Marshall, Alison Rodger, Sanjay Bhagani, The United Kingdom
300 The International Liver Congress™ 2015 • ILC Programme
